2,543
Views
10
CrossRef citations to date
0
Altmetric
Original Research

Predictive role of plasmatic biomarkers in advanced non-small cell lung cancer treated by nivolumab

, , , , , , , , , & show all
Article: e1452581 | Received 11 Jan 2018, Accepted 09 Mar 2018, Published online: 20 Apr 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (10)

Xiaorong Peng, Ran Tao, Ying Chen, Junwei Su, Ying Huang & Biao Zhu. (2022) Transient HIV Reservoirs and Interleukin-6 Increase After Anti-Programmed Death-1 Antibody Infusion in HIV Patients with Lung Cancer. Journal of Inflammation Research 15, pages 199-204.
Read now
Rong Fu, Chuan-Qing Jing, Xiu-Rong Li, Zhao-Feng Tan & Hui-Jie Li. (2021) Prognostic Significance of Serum PD-L1 Level in Patients with Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma Treated with Combination Cytotoxic Chemotherapy. Cancer Management and Research 13, pages 4935-4946.
Read now
Marco Massafra, Maria Ilenia Passalacqua, Vittorio Gebbia, Paolo Macrì, Chiara Lazzari, Vanesa Gregorc, Carmelo Buda, Giuseppe Altavilla & Mariacarmela Santarpia. (2021) Immunotherapeutic Advances for NSCLC. Biologics: Targets and Therapy 15, pages 399-417.
Read now
Tianzhu Lu, Yiping Chen, Jieyu Li, Qiaojuan Guo, Wansong Lin, Yuhong Zheng, Ying Su, Jingfeng Zong, Shaojun Lin, Yunbin Ye & Jianji Pan. (2020) High Soluble Programmed Death-Ligand 1 Predicts Poor Prognosis in Patients with Nasopharyngeal Carcinoma. OncoTargets and Therapy 13, pages 1757-1765.
Read now
Sidhant Jain & Sahil Kumar. (2020) Cancer immunotherapy: dawn of the death of cancer?. International Reviews of Immunology 39:5, pages 205-222.
Read now
Julie Le Naour, Lorenzo Galluzzi, Laurence Zitvogel, Guido Kroemer & Erika Vacchelli. (2020) Trial watch: IDO inhibitors in cancer therapy. OncoImmunology 9:1.
Read now
Julie Le Naour, Laurence Zitvogel, Lorenzo Galluzzi, Erika Vacchelli & Guido Kroemer. (2020) Trial watch: STING agonists in cancer therapy. OncoImmunology 9:1.
Read now
Julie Le Naour, Lorenzo Galluzzi, Laurence Zitvogel, Guido Kroemer & Erika Vacchelli. (2020) Trial watch: TLR3 agonists in cancer therapy. OncoImmunology 9:1.
Read now
Jacob J. Orme, Khalid A. Jazieh, Tiancheng Xie, Susan Harrington, Xin Liu, Matthew Ball, Benjamin Madden, M. Cristine Charlesworth, Tariq U. Azam, Fabrice Lucien, Bharath Wootla, Yanli Li, Jose Caetano Villasboas, Aaron S. Mansfield, Roxana S. Dronca & Haidong Dong. (2020) ADAM10 and ADAM17 cleave PD-L1 to mediate PD-(L)1 inhibitor resistance. OncoImmunology 9:1.
Read now
Martyna Filipska, Carlos Pedraz-Valdunciel, Imane Chaib & Rafael Rosell. (2019) Biological therapies in lung cancer treatment: using our immune system as an ally to defeat the malignancy. Expert Opinion on Biological Therapy 19:5, pages 457-467.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.